Marketresearchnews

Tuesday, 9 February 2021

Flexible Spinal Implants Market Ready for a Record-Breaking growth by 2023

Technological advancements in spine implants, increasing aging and obese population, rising cases of spine deformities, demand for minimally invasive spine surgery, growth in the number of hospitals offering spinal surgeries are fueling the growth of global flexible spinal implants market. The market restraints are stringent product approval process, uncertain reimbursement scenario, high cost of treatment procedures, concerns about safety of advanced products etc.

Considering all these factors the market for flexible spinal implants is expected to reach 4 billion USD by the end of 2023, this market is projected to growing at a CAGR of ~ 13.2 % during 2017-2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/779

Key Players of Global Flexible Spinal Implants Market:

Key players profiled in the report are Paradigm Spine LLC, Medtronic plc., Abbott Spine, Inc., Raymedica, K2M Group Holdings, Stryker Corporation, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Alphatec Holdings, Inc., NuVasive, Inc., Orthofix International N.V., and others.
Intended Audience

Global flexible spinal implants solution providers, manufacturers & suppliers
Research and development (R&D) companies
Market research and consulting service providers
Academic institutes and universities

Market Segments:

The global flexible spinal implants market is segmented on the basis of type and applications. Based on type, the market has been segmented as rods, hooks, pedicle screws, plates, cages and other. Based on the applications, the market has been segmented as thoracic, lumbar, cervical, artificial discs and other.

Study objectives:

To provide a detailed analysis of the market structure along with estimated future growth forecast for the next 6 years about various segments and sub-segments of the global flexible spinal implants market.
To provide insights about factors affecting the market growth.
To analyze the global flexible spinal implants market based on various factors – price analysis, supply chain analysis, Porters Five Force analysis etc.
To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries – Americas, Europe, Asia Pacific along with Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future growth prospects.
To provide country level analysis of the market’s segments which includes by type and applications.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape of the market.
To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new disease developments along with research and developments that are currently taking place in the global flexible spinal implants markets.

Regional Aanalysis:

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is the fastest region because of large unmet needs which is led by China and India. The Middle East and Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/flexible-spinal-implants-market-3755

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Muscle Stimulator Market Racing to a Heightened Growth by 2023

The muscle stimulators use electric current to elicit contraction in muscles or nerves. The electric signal has intensity and frequency which mimics the nerve signal system. The market for muscle stimulator is rising due to drivers such as increasing popularity of sports and increased demand for fitness products, increasing healthcare expenditure and rising affordability of muscle stimulators, demand for non-invasive technology devices and growing preference for muscle stimulators among physiotherapists etc. The rising population of geriatrics is also a strong stimulant. According to the world health organization by 2050, the world’s population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/779

The world health organization also estimates that today, 125 million people are aged 80 years or older. Thus the huge rise in geriatrics around the globe, will drive the market due to greater frequency of muscle ailments in the geriatrics population. There has been increasing incidence of muscle diseases and disorders such as low back pain, spinal injuries etc. are driving the market. The rise of risk factors such as growing prevalence of diabetes, increasing incidence of accident injuries, occupational injuries etc. is driving the growth of these diseases.

The restraints include competition from alternative therapies such as acupuncture, yoga, and aroma therapy etc., lack of usage guidelines and safety concerns and regulatory uncertainties in the US.

Considering all these factors the market for muscle stimulator is expected to reach $ 768.3 million by the end of 2023, this market is projected to growing at a CAGR of ~ 6.1 % during 2017-2023.
Study objectives:

To provide detail analysis of the market structure along with estimated future growth forecast for the next 6 years about various segments and sub-segments of the global muscle stimulator market.
To provide insights about factors affecting the market growth.
To analyze the global muscle stimulator market based on various factors – price analysis, supply chain analysis, Porters Five Force Analysis etc.
To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries – Americas, Europe, Asia-Pacific along with Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future growth prospect.
To provide country level analysis of the market’s segments which includes by products, and by application.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies and drawing a competitive landscape of the market.
To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new disease developments along with research and developments currently taking place in the global muscle stimulator market.

Key players of Global Muscle stimulator Market:

Key players profiled in the report are DJO Global, Inc., Mettler Electronics Corp., Axiobionics, Zynex, NeuroMetrix, Inc., OMRON Corporation, Tone-A-Matic and others.

Segments:

The global muscle stimulator market is segmented on the basis of products. Based on the products, the market has been segmented as transcutaneous electrical nerve stimulator, burst mode alternating current, neuromuscular electric stimulation, and interferential current. Based on the application, the market has been segmented as pain management, neurological and movement disorder management and musculoskeletal disorder management.

Regional analysis

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and rising awareness. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/muscle-stimulator-market-779

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Acute Myeloid Leukemia Treatment Market to Significant Growth Foreseen by 2023

Market Scenario

The Market for Acute Myeloid Leukemia Treatment is expected to reach $ 1.2 billion by the end of 2023, this market is projected to growing at a CAGR of Approximately 5.3 % during 2017-2023.

Acute myeloid leukemia (AML) is a cancer of the myeloid blood cells, causing extreme and rapid growth of abnormal white blood cells of the bone marrow. The rapid buildup of abnormal white blood cells causes interference in the production of normal blood cells. AML has a propensity to increase towards age. Replacement of normal bone marrow with cancer cells causes a drop in blood constituents such as red blood cells, platelets, white blood cells etc. which causes symptoms such as fatigue, breathlessness, easy bruising and bleeding, and increased risk of infection. The market driving factors for acute myeloid leukemia (AML) are rise in risk factors such as exposures to carcinogens such as ionizing radiation, chemicals etc. Presence of other blood disorders and genetics is also involved for the higher risk of AML. Other market drivers are increasing number of cancer hospitals, greater awareness, good reimbursement scenario etc. The market constraints are poor cure rates of the present drugs, serious side effects of the drugs etc.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3223

The market driving factors are the rising number of stem cell banks and the increase in genetic profiling of cancer genes which is increasing the understanding of AML. The increasing interest and expenditure as well as grants for stem cell research will lead to future growth due to their high potential.

Key players of Global Acute Myeloid Leukemia Treatment Market

Johnson & Johnson
Pfizer Inc.
Celgene Corporation
Ambit Biosciences Corporation
Cyclacel Pharmaceuticals Inc.
Novartis AG and Sanofi
Bristol Myers Squibb

Segmentation of Global Acute Myeloid Leukemia Treatment Market

The global acute myeloid leukemia treatment market is segmented on the basis of disease type. Based on the disease type, the market has been segmented as myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia and megakaryocytic. Based on the treatment, the market has been segmented as chemotherapy, and hematopoietic stem cell transplantation. Chemotherapy is further sub-segmented into induction and post remission.

Regional Analysis of Acute Myeloid Leukemia Treatment Market

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and presence of large hospitals. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.

The report for Global Acute myeloid leukemia treatment Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Browse Complete 108 Pages Premium Research Report Enabled with 121 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/acute-myeloid-leukemia-treatment-market-3223

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Lithotripsy Market Foreseen to Draw a Promising Growth by 2023

Lithotripsy is medical procedure that break kidney stones in small pieces. It use shock wave to break kidney stones so that it can travel through urinary track and remove from the body. Changing technology and innovation are major driving forces for the global lithotripsy market. Increasing adoption of new products and rising demand for advanced medical instruments are key factors for market growth. Major manufactures are increasing funding for new product development that leading to innovation and increasing competition in this market. Increasing burden of kidney stone is major factor for market growth.

The Global Lithotripsy market is growing at the CAGR of ~4.1% during the forecast period and expected to reach US$ 524.9 million by 2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3200

Segments:

Global Lithotripsy Market has been segmented on the basis of type Extracorporeal shock wave lithotripsy (ESWL), Intracorporeal (endoscopic lithotripsy), Percutaneous lithotripsy, and others. Intracorporeal is further sub segmented into Laser lithotripsy, electrohydraulic lithotripsy, Mechanical lithotripsy, and Ultrasonic lithotripsy. On the basis of end user market is segmented into Hospitals and clinics, Research laboratories, Academic Institutes, and others.

Regional Analysis of Global Lithotripsy Market:

Considering the global scenario of the market, Americas holds the largest market share for the global lithotripsy market. In Americas, U.S. accounts the largest market share due to the high adoption of the advanced technology by healthcare professionals and high demand for advanced medical instruments. European is second largest region in global lithotripsy market where Western European countries accounts the largest share of this region. On the other hand, Asia-Pacific (APAC) is fastest growing market and expected to dominate the market by 2023. Middle East and Africa (ME&A) is likely to have a restricted growth in the market due to less awareness of devices and treatment.

Key Players for Global Lithotripsy Market:

Some of the key players in this market are: Boston Scientific (US), DIREX, S.L. (Spain), Dornier MedTech.(Germany), EDAP TMS (France), Elmed Electronics & Medical Industry & Trade Inc.(Turkey), Jena Med Tech GmbH (Germany), Medispec LTD (US), Olympus Corporation (Japan), Siemens Healthcare GmbH (Germany), STORZ MEDICAL AG (Switzerland)

The report for Global Lithotripsy Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/lithotripsy-market-3200

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Mhealth Applications Market Projected to Witness Vigorous Expansion by 2023

mHealth is one of the most innovative and disruptive trends in healthcare sector that is growing at prodigious rate from last few years. mHealth is changing the way of traditional medical practices and creating path for the future of healthcare. mHealth assists to check and maintain the health related activity by using technology such as Bluetooth, mobile network (GSM/GPRS/3G/4G), and Wi-Fi. The data collected by mHealth devices such as mobile phones, tablets, laptops and tablet PCs assist to medical professional, consumers, and other users.

Considering the global scenario of the mHealth applications market, the total market for mHealth application was US$ XX billion in 2016 and expected to reach US$ 100.2 billion by 2023. While considering the segments, monitoring application is holding largest market share that is about 53.8% in 2016.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3195

Key Players for Global mHealth Applications Market:

Some of the key players in this market are: Allscripts (US), Agamatrix, Inc. (US), Apple Inc. (US), Honeywell International Inc. (US), Medtronic MiniMed, Inc. (US), Vivify Health (US) and iHealth Labs Inc. (US).

Segments:

Global MHealth applications Market has been segmented on the basis of type which comprise Monitoring Applications, Diagnosis & Treatment, Education & Awareness, Healthcare Management, Wellness & Prevention, and others.

Research Methodology:

Regional Analysis of Global mHealth applications Market:

Considering the global scenario of the market, Europe was holding largest market share of 31.7% in global mHealth applications market in 2016. Asia-Pacific is second largest and fastest growing market in global mHealth applications market. APAC is expected to grow at a CAGR of 33.7% during 2017-2023. North America is one of pioneer in mhealth and is slightly behind the APAC. North America is expected to reach USD 28762.1 million by 2023. On the other hand. Middle East and Africa (ME&A) mHealth was valued USD 1334.9 in 2016 and is expected to grow at steady pace during the forecast period.

The report for Global mHealth Applications Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/mhealth-applications-market-3195

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Safety lancet Market Plying for Significant Growth During 2020 - 2023

The Safety Lancet Market is a dynamic and vital component of the healthcare industry. Developments in the medical device industry are made to simplify the diagnosis, prevention and treatment of various diseases. Every component of this industry plays an important role in the Safety Lancet Market sizing. One of such device is safety lancet, which is capturing a huge market share due to its application. The Safety Lancet Market can be further divided into push button safety lancet, pressure activated safety lancet and side button safety lancet.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/550

The global Safety Lancet Market is expected to reach USD 2,305.1 million in 2023 from USD 1,056.2 million in 2016 with a CAGR of 11.8% during the forecast period 2017-2023.

Key Players for Global Safety Lancet Market:

Some of the key players in this Safety Lancet Market are: F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Terumo Medical Corporation, Bayer AG, HTL-STREFA S.A., Sarstedt AG & Co., Improve Medical Technology Co. Ltd and others.

Safety Lancet Market Segments:

Global Safety lancet Market has been segmented on the basis of types which comprises of push button safety lancet, pressure activated safety lancet and side button safety lancet. On the basis of end user, it comprises of hospitals & clinics, diagnostic centers and pathology laboratories, home diagnostics and other end users.

Regional Analysis of Global Safety Lancet Market:

The global Safety Lancet Market is growing steadily. The Safety Lancet Market is growing with the CAGR of 11.8% during the forecast period from 2017-2023. Blood sampling safety lancet are the most common devices used in hospitals, clinics, diagnostic centers and home monitoring. The global safety lancet market reached USD 2,305.1 million in 2023 from 1,056.2 million in 2016. Europe region captured the largest Safety Lancet Market globally and is expected to reach USD 1,032.7 million by 2023 due to the growing demand and need for safe blood glucose tests in hospitals, clinics, diagnostics centers etc. and the growth of insulin users.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/safety-lancet-market-550

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Glaucoma Treatment Market Foreseen to Draw a Promising Growth by 2023

Glaucoma is a disease characterized by fluid builds up in the front part of your eye which results in damages to the eye’s optic nerve which may lead to blindness if left untreated. Open angle glaucoma (OAG) is the most common type of glaucoma followed by closed angle glaucoma (CAG) and these two account for greater than 50% of glaucoma cases. According to World Health Organization (WHO) estimates, Glaucoma is the second most common cause of blindness worldwide after cataract.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2962

The market for glaucoma is increasing at an impressive rate primarily driven by the growing number of geriatrics. Older population has higher risk of developing glaucoma although other age groups may be affected. Other high risk groups include diabetics and those with a family history of glaucoma. The other market driving factors are increasing awareness, growing healthcare expenditure and screening etc.

The product development strategies have been very impressive with the surgery option. The last decade has seen impressive additions to the surgery options such as laser therapy, photodynamic therapy etc. The market constraints are excellent efficacy and efficiency of present drugs especially prostaglandin analogs and carbonic anhydrase inhibitors, which has set the bar for a new therapy extremely high and the loss of patent protection on the major drugs used to treat glaucoma.

Taking all factors into consideration, we expect the Asia Pacific glaucoma treatment market to reach around $ 888.94 million in 2023 from $576.0 million in 2017, by the end of the forecast period at a CAGR of ~ 7.5 %. While the glaucoma drug market will grow by a flat CAGR of 2.1% the glaucoma surgery market is poised for an explosive CAGR of 18.5 %.

Key Players for Asia-Pacific Glaucoma Treatment Market:

Some of the key players in this market are: Novartis AG, Pfizer Inc., Allergan, Merck & Co., Ocular Therapeutix Inc, pSivida Corp, Icon Bioscience Inc, Amorphex Therapeutics LLC., Ellex, Quantel, Lumenis, and Lightmed among others.

Segments:

Asia-Pacific Glaucoma Treatment Market has been segmented on the basis of disease indication which comprises Closed Angle Glaucoma (CAG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma and other. On the basis of drug class; market is segmented into prostaglandin analogs (PGAS), alpha agonist, beta blockers, cholinergic drugs, carbonic anhydrase inhibitors, and others. On the basis of surgery; market is segmented into laser iridotomy, laser trabeculoplasty, aqueous shunt surgery and peripheral iridectomy. On the basis of end users; market is segmented into hospitals and home users.

Regional Analysis of Asia-Pacific Glaucoma Treatment Market:

The healthcare sector of Asia Pacific varies immensely by countries. However the Asia Pacific region has lower public sector expenditure and most treatments involve out of pocket expenditure. Further the eye care has been a neglected segment especially in the poor countries of Asia Pacific region. Japan and South Korea are the leading markets while China will be the fastest growing due to rising healthcare expenditure and faster economic growth. Also the presence of strong generics especially in nations like India will lead to volume growth of anti-glaucoma drugs. The surgery market however will see fastest growth in Japan as compared to developing parts of Asia Pacific.

The report for Asia-Pacific Glaucoma Treatment Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/asia-pacific-glaucoma-treatment-market-2962

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com